#Orthotwitter – This systematic review suggests there may be a benefit to concomitant treatment with bone marrow aspirate concentrate (BMAC) at the time of hip arthroscopy. https://t.co/H1eayw4LsG

#ICYMI | Early results of this preliminary post-market approval study suggest that bridge-enhanced ACL restoration (BEAR) may provide a safe and non-inferior approach to anterior cruciate ligament (ACL) reconstruction in selected patients. https://t.co/pVI7nGIsuA

#NarrativeReview | Evidence suggests clinical uses for adipose-derived cell therapies for wound healing and osteoarthritis but large-scale trials are needed to confirm efficacy and optimize clinical translation.  https://t.co/5u6hPOJBRx

#orthotwitter – This scoping review found that the efficacy of bone-marrow derived stem cells (BM-MSC) therapy alone in the treatment of hip osteoarthritis appeared beneficial, improving clinical outcomes in each study. https://t.co/SWDFmp9vly

🔔 #ICYMI | "Bone Marrow Aspirate Concentrate With Hip Arthroscopy in a Heterogenous Group of Patients May Result in Improved Patient-Reported Outcomes: A Systematic Review" is FREE to access for a limited time. #MedTwitter https://t.co/lxTb5J5SRH

#OpenAccess | This study of regeneration of the sciatic nerve in a rat model suggests the feasibility of 3D-printed topographical scaffolds. More research is required to quantify the functional outcomes of this technology for peripheral nerve regeneration. https://t.co/n9plG3ugF7

#ICYMI | This review article provides historical context of stem cell research, ethical issues such as informed consent, therapeutic misconception, and equitable access, emphasizing the responsibilities of providers offering investigational treatments. https://t.co/1pvCfvyiom

This review suggests that the treatment of knee osteoarthritis with autologous mesenchymal stem cell injections is safe in the short term; however, further studies are needed to better quantify their short-term adverse events and confirm long-term safety. https://t.co/k8RvVFboit

#orthotwitter – This article reviews preclinical and clinical evidence on the potential of exosomes in treating musculoskeletal and neurological disorders. Read our #OpenAccess article to learn more: https://t.co/jxJcMuNXqr

In preclinical models BPC-157 has been found to reduce inflammation and augment biomechanical and functional recovery in musculoskeletal injury. These uses have not been studied in humans & top sports leagues have banned BPC-157. #orthotwitter https://t.co/B9Qsc3Il5w

#ReviewArticle | Authors consider autologous conditioned serum, alpha-2-macroglobulin, and autologous protein solution and the current basic science and clinical literature on their potential utility as therapeutics for various orthopedic conditions. https://t.co/UEJZbjD6BH

The integration of artificial intelligence and virtual reality into orthopedic surgery is affecting surgical precision, training for surgeons, patient engagement, and personalized treatment strategies. Read our #OpenAccess review article to learn more: https://t.co/Gyh3JnrW5w

🚨 Special Issue Alert! #orthotwitter – Our November issue focuses on regenerative medicine in musculoskeletal care: https://t.co/Nowm6hYli9 Thank you to our guest editors, Scott Rodeo, MD and Steven Cohen, MD.

@HSS_Journal @KECKSchool_USC @drpetrigliano @CailanFeingold Really interesting way to look at how orthopaedic research is used! Tough to lump all indications for MSCs together though. What may help meniscal repair, may be less helpful for osteoarthritis. Super interesting! @heckmannortho @BrianChalmersMD @jointdocShields

Review found that 5 commercial insurance payers substantiate their denial of coverage for mesenchymal stem cell (MSC) use in ortho applications w/ primarily low-level evidence & that higher-level evidence demonstrates the efficacy of MSCs at higher rates. https://t.co/z4MlkM1G8J

#OpenAccess | As Artificial intelligence (AI) capabilities evolve, a balanced approach fostering innovation without compromising safety and equity will be essential in realizing AI’s full potential in musculoskeletal healthcare. #digitalhealth https://t.co/giS8b0KhVq

The adoption of AI applications in musculoskeletal healthcare is inevitable. #orthotwitter – Read our recent guest editorial, "Artificial Intelligence and Digital Applications in Musculoskeletal Healthcare: Ready or Not, Here It Comes!", to learn more: https://t.co/l9EBPpCiOi

🔔 Virtual learning opportunity! Experts will review regenerative therapies and highlight best practices in orthopaedics, sports medicine, & rehabilitation on November 3. Register for "Regenerative Medicine in Musculoskeletal Care: Evidence vs Hype": https://t.co/H6tJAMGLiH

Study suggests that titanium transcutaneous osseointegrated nail seems safe & reasonable to offer to patients seeking improved mobility & quality of life after amputation for total knee arthroplasty (TKA) periprosthetic joint infection (PJI) management. https://t.co/gBMe99UdGa

New CME article! This review introduces critical concepts of generative AI, presents clinical applications relevant to musculoskeletal healthcare that are in development, & highlights limitations preventing deployment in clinical settings. #orthotwitter https://t.co/2I8L1mAV9x